Third Pole

Third Pole, Inc. is a company based in Waltham, Massachusetts, comprised of 42 employees. The company focuses on the development of innovative cardiopulmonary therapies. Third Pole is dedicated to creating next-generation life-saving heart and lung therapies, building upon the success of inhaled nitric oxide (NO), the current standard of care. Their primary product in development is a user-friendly device designed to generate nitric oxide from ambient air on-demand and on-site. This innovative approach eliminates the need for large, cumbersome compressed gas cylinders and has the potential to significantly expand the accessibility of inhaled NO therapy. Third Pole's vision is to make inhaled NO therapy widely available, moving beyond the constraints of acute care settings. By creating a simple, convenient, economical, and lightweight device, they aim to open up new markets and improve patient care globally. For more information about Third Pole and their groundbreaking therapies, please visit their website at pole3.com.